Sarah Owermohle reported on the administration’s health care initiatives, federal health policy, and its intersection with politics and the courts. She joined STAT in 2022 after covering health policy at Politico. She was also the co-author of the free, twice-weekly D.C. Diagnosis newsletter.
Lizzy leads STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the FDA, industry influence, and the agency’s ability to protect and promote public health. Confidential tips can be sent on Signal at lizzylaw.53.
Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Follow her on Mastodon and Bluesky. You can reach Helen on Signal at hbranswell.01.
Matthew Herper covers medical innovation — both its promise and its perils.
WASHINGTON — The Trump administration is set to eliminate thousands of federal health care jobs Friday, targeting employees across public health and science agencies who were hired in the past one to two years.
Senior officials were informed in meetings Friday morning that roughly 5,200 people on probationary employment — recent hires — across agencies including the National Institutes of Health and the Centers for Disease Control and Prevention will be fired that afternoon, according to sources briefed on the meetings. CDC leadership was told the Atlanta-based agency would lose about 1,300 workers. The numbers at the NIH are not clear, but exceptions are being made for certain probationary employees, according to a memo viewed by STAT.
The workers will be given a month’s paid leave but lose access to work systems by the end of Friday, according to sources.
STAT+ Exclusive Story
Already have an account? Log in
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.
Already have an account? Log in
To read the rest of this story subscribe to STAT+.
-
Sarah Owermohle reported on the administration’s health care initiatives, federal health policy, and its intersection with politics and the courts. She joined STAT in 2022 after covering health policy at Politico. She was also the co-author of the free, twice-weekly D.C. Diagnosis newsletter.
-
Lizzy leads STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the FDA, industry influence, and the agency’s ability to protect and promote public health. Confidential tips can be sent on Signal at lizzylaw.53.
